The comparative risk of new-onset diabetes after prescription of drugs for cardiovascular risk prevention in primary care: a national cohort study
Open Access
Abstract
Objective Recent studies suggest that statins increase the risk of subsequent diabetes with a clear dose response effect. However, patients prescribed statins have a higher background risk of diabetes. This national cohort study aims to provide an estimate of the comparative risks for subsequent development of new-onset diabetes in adults prescribed statins and in those with an already higher background risk on cardiovascular risk-modifying drugs and a control drug. Design Longitudinal cohort study. Setting Use of routinely collected data from a complete national primary care electronic prescription database in New Zealand. Participants 32 086 patients aged between 40 and 60 years in 2005 were eligible and assigned to four non-overlapping groups receiving their first prescription for: (1) diclofenac (healthy population) n=7140; (2) antihypertensives thought likely to induce diabetes (thiazides and β-blockers) n=5769; (3) antihypertensives thought less likely to induce diabetes (ACE inhibitors, angiotensin II receptor blockers, calcium channel blocker) n=6565 and (4) statins n=12 612. Outcome Numbers of first metformin prescriptions were compared between these groups from 2006 to 2011. Results Patients prescribed statins have the highest risk of receiving a subsequent metformin prescription (HR 3.31; 95% CI 2.56 to 4.30; pConclusions These findings further support the link between statin use and new-onset diabetes and suggest that the understanding of diabetes risk associated with different antihypertensive drug classes may bear practice modification. This provides important information for future research, and for prescribers and patients when considering the risks and benefits of different types of cardiovascular risk-modifying drugs.Keywords
This publication has 25 references indexed in Scilit:
- Statins, Risk of Diabetes, and Implications on Outcomes in the General PopulationJACC, 2012
- Statins and New-Onset Diabetes: A Retrospective Longitudinal Cohort StudyClinical Therapeutics, 2012
- Blood Pressure Responses and Metabolic Effects of Hydrochlorothiazide and AtenololAmerican Journal of Hypertension, 2012
- Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women's Health InitiativeArchives of internal medicine (1960), 2012
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin TherapyJAMA, 2011
- Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch databaseBMJ, 2010
- Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patientsAtherosclerosis, 2008
- New-onset diabetes and antihypertensive drugsJournal Of Hypertension, 2006
- Adverse Prognostic Significance of New Diabetes in Treated Hypertensive SubjectsHypertension, 2004
- Increased occurrence of diabetes in people with ischemic cardiovascular disease and general and abdominal obesity.2003